Cargando…
Quantitative assessment of chemotherapy‐induced peripheral neurotoxicity using a point‐of‐care nerve conduction device
Chemotherapy‐induced peripheral neurotoxicity (CIPN) seriously impairs patients’ quality of life cumulatively and dose‐dependently. Because assessment of CIPN usually depends on patients’ subjective evaluation of symptoms, objective and quantitative measures are needed. We evaluated a point‐of‐care...
Autores principales: | Matsuoka, Ayumu, Mitsuma, Ayako, Maeda, Osamu, Kajiyama, Hiroaki, Kiyoi, Hitoshi, Kodera, Yasuhiro, Nagino, Masato, Goto, Hidemi, Ando, Yuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084655/ https://www.ncbi.nlm.nih.gov/pubmed/27412083 http://dx.doi.org/10.1111/cas.13010 |
Ejemplares similares
-
Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study
por: Maeda, Osamu, et al.
Publicado: (2017) -
Chemotherapy for biliary tract cancer: real-world experience in a single institute
por: Maeda, Osamu, et al.
Publicado: (2020) -
Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction
por: Shibata, Takashi, et al.
Publicado: (2016) -
Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review
por: Maeda, Osamu, et al.
Publicado: (2020) -
Bevacizumab Exacerbates Paclitaxel-Induced Neuropathy: A Retrospective Cohort Study
por: Matsuoka, Ayumu, et al.
Publicado: (2016)